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Averrhoa carambola L., a species belonging to the Oxalidaceae family, is associated with neurological 
symptoms in individuals with renal diseases. The objective of this work was to accomplish a pre-
clinical toxicological study of the hydroalcoholic extract (HE) from A. carambola leaves. Wistar rats and 
Swiss mice, both male and female, were used in these experiments. The rats were used in the acute 
toxicity assessment, with the extract administered at doses of 0.1 to 8.0 g/kg (oral route), and 0.5 to 3.0 
g/kg (via intraperitoneal route). The mice received the extract in doses of 0.5 to 5.0 g/kg (via oral and 
intraperitoneal routes) and were observed for 14 days. Rats were also used in the sub-chronic toxicity 
evaluation, and divided into three groups (n=10): control group, HE 0.125 g/kg and HE 0.25 g/kg. These 
animals received HE for a 60 day period, at the end of which a macroscopic analysis of selected organs 
was performed with biochemical analysis of the blood. The acute toxicity assessment revealed that the 
HE of A. carambola L. presented low toxicity in the mice and rats. Furthermore, no signs of toxicity 
were present in the sub-chronic assessment. 
 





The use of medicinal plants is common in popular culture, 
where it represents the result of centuries of accumu-
lation of empirical knowledge on the action of plants by 
diverse ethnic groups. Some of the most valuable and 
most widely used medicines were developed from the 
accumulation of this knowledge (Simoes, 1989). The 
species Averrhoa carambola L., popularly known in Brazil 
as “carambola” (starfruit), belongs to the Oxalidaceae 
family. This family is comprised of eight genera distribu-
ted predominantly in the southern hemisphere, in the 
tropical and subtropical zones, and made up of trees 
cultivated for ornamental purposes because of their fruit 
(Carreira and Schatzmayr, 1982; Joly, 1979). Two species 
are present in this genus: A. carambola L. and Averrhoa 
bilimbi L. The assessment of the physicoche-mical cha-
racteristics of the fruits of A. bilimbi L. showed the 
presence of oxalic acid and ascorbic acid (Lima et al., 
2001). Hypolipidemic and hypoglycemic activities were 
observed using this plant species in Sprague-Dawley rats 
with induced diabetes (Tan et al., 2005) and the methanol 
extract from the leaves was shown to contain antioxidant 
activity (Abas et al., 2006). 
Popularly, A. carambola L. is used as an anti-thermal, 
against the bites of poisonous animals, and as an anti-
dysentery and anti-scurvy treatment. Chemical and phy-
tochemical analyses performed on the plant revealed
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the presence of oxalic acid, vitamin C and tannins (Prance, 
1975), moderate amounts of sugar, fiber, and calcium, as 
well as a low phosphorus and iron content (Oliveira et al., 
1989), isoforms of the galactoside enzymes 
(Balasubramanian et al., 2005), volatile compounds 
(Macleod and Ames, 1990) and carotenoids (Gross et al., 
1983). Several studies have reported that the ingestion of 
A. carambola L. fruit is related to the appearance of 
neurological symptoms in individuals affected by renal 
insufficiency, with symptoms including intractable hiccups, 
vomiting, paresthesias, paresis of the upper and lower 
limbs and several different disturbances related to con-
sciousness present in varying degrees (Moysés et al., 
1998; Tse et al., 2003; Moysés and Mep, 2004; Lo et al., 
2001; Wu et al., 2002; Yap et al., 2002; Chan et al., 
2002). Provasi et al. (2001) investigated the acute toxicity 
of A. carambola L. in doses of 3.5 g/kg in mice and 1.14 
g/kg in rats by intra-gastric route and did not observe any 
deaths among treated animals in the 4 h following the 
administration of the extract. On the other hand, Signate 
et al. (2009) reported the cases of two patients with un-
diagnosed chronic renal insufficiency who developed 
severe encephalopathy after ingestion of star fruit. The 
two patients developed intractable hiccups, vomiting, 
impaired consciousness and status epilepticus. Diffusion-
weighted magnetic resonance imaging showed cortical 
and thalamic hyperintense lesions related to epileptic 
status.  
The use of insoluble fibers of the A. carambola L. fruit 
had beneficial effects on intestinal activity, leading to a 
decrease in the pH in the cecum, together with a de-
crease in the cecal and fecal ammonia levels (Chau and 
Chen, 2006). In addition to their effects on digestive 
system function, the insoluble fibers present in the fruit, 
when evaluated against glycemia in vitro demonstrated 
potential hypoglycemic activity, besides inhibiting the 
enzyme alpha amylase (Chau et al., 2004). Provasi et al. 
(2001) observed that a 30 mg/kg dose of extract from the 
leaves of A. carambola L. had anti-hypoglycemic activity 
in rats and when the authors examined the effect of the 
crude hydroalcoholic extract and isolated fractions of 
leaves on the glucose metabolism in Wistar rats treated 
for two weeks with a 20 mg/kg dose, they found a 
reduction in glycemia. However, when the extract’s acti-
vities were investigated in isolated muscle, there was no 
stimulation of the production of glycogen and lactate 
(Provasi et al., 2005). In a study on the effect of the 
hydroalcoholic extract of the leaves on glycemia during 
fasting in rats treated orally (20 mg/kg), we found that the 
A. carambola L. extract lowered glycemia in comparison 
with the control group, while this reduction was not caused 
by inhibition of hepatic gluconeogenesis nor by an increase 
in glucose uptake by muscle (Ferreira et al., 2008).  
Anti-inflammatory activity was observed in the skin of 
mice treated with the crude ethanolic extract of A. 
carambola leaves, as well as its hexane, ethyl acetate, 





activity was measured using a croton oil-induced ear 
edema model of inflammation, and topically applied 
ethanolic extract reduced edema in a dose-dependent 
manner, with a maximum inhibition of 73±3% and an ID50 
value of 0.05 (range: 0.02–0.13) mg/ear. Myeloperoxi-
dase (MPO) activity was also inhibited by the extract, with 
a maximum inhibition of 60±6% (0.6 mg/ear). All of the 
fractions tested inhibited edema formation as well as 
MPO activity, although treatment with the ethyl acetate 
fraction was the most effective, resulting in inhibition of 
75±5 and 54±8% for edema formation and MPO activity, 
respectively. However, treatment of mice with isolated 
compounds [apigenin-6-Cb- L-fucopyranoside and 
apigenin-6-C-(200-O-a-L-rhamnopyranosyl)-b-L-
fucopyranoside] did not yield notable results, with the 
latter compound causing only a mild reduction in edema 
formation (28± 11%) (Cabrini et al., 2011).  
In another work, Khoo et al. (2010) examined the toxic 
effect of A. carambola juice, kept under different storage 
conditions, in Sprague Dawley (SD) rats, observing no 
deaths and consequently being unable to determine the 
LD50 for the juice. The authors did report an increase in 
alanine aminotransferase (ALT) levels (P < 0.05) in those 
rats treated with A. carambola juice stored for 3 h.  
Studies that examine the potential toxicity of A. carambola 
L. remain scarce, which explains the importance of 
assessing its toxic effects in experimental studies. The 
objective of this work was to assess the acute and sub-
chronic toxicity of the hydroalcoholic extract of A. 
carambola L. leaves in rats and mice. 
 
 
MATERIALS AND METHODS 
 
Plant material and extract preparation 
 
The A. carambola L. leaves were collected from the municipal area 
of Paço do Lumiar, in the state of Maranhão, Brazil in February 
2006, and identified at the “Atico Seabra” herbarium (Federal 
University of Maranhão), where a voucher specimen was registered 
under number 0561 SLS/MA. The hydroalcoholic extract (HE) was 
obtained from the dehydrated and ground leaves by maceration in 
70% ethanol for 72 h. Next, the extract was concentrated in a rotary 
evaporator at a reduced pressure and at a temperature of 50°C. 





The experiments were carried out in Wistar rats (Rattus norvegicus), 
between 60 and 90 days of age, weighing between 220 and 360 g 
(male) and between 135 and 260 g (female), and Swiss mice (Mus 
musculus), between 60 and 90 days of age, weighing between 26 
and 32 g (male) and between 21 and 28 g (female), supplied by the 
Central Animal Facility of the Federal University of Maranhão. 
These animals were divided into groups of 6 to 10, including both 
males and females, according to the experiment performed. The 
control animals (CT, rats and mice respectively) received water at 
0.1 ml/100 g or 0.1ml /10g body weight and the remaining animals 
received HE at varying doses. The results obtained with the HE are 
compared to the control animals. Animals were handled based on 
the guidelines of the animal ethics committee of the Universidade 
Estadual do Maranhão (UEMA), who approved this research 





Assessment of acute toxicity 
 
The experimental protocols for the assessment of acute toxicity 
were mainly based on the Specific Resolution (SR 90/2004) of the 
National Sanitary Vigilance Agency (ANVISA; Brazil, 2004). Rats 
and mice were divided into five or six experimental groups with ten 
animals each (five male and five female), and increasing doses of 
extract were administered. The rats received the following via 
intraperitoneal route (i.p.): water (CT group), A. carambola L. 
hydroalcoholic extract at doses of 0.5 g/kg (group HE 0.5), 1.0 g/kg 
(group HE 1.0), 2.0 g/kg (group HE 2.0) and 3.0 g/kg (group HE 
3.0). By oral route (v.o.), they were given: water (CT group), A. 
carambola L. HE at doses of 1.0 g/kg (group HE 1.0), 2.0 g/kg 
(group HE 2.0), 5.0 g/kg (group HE 5.0) and 8.0 g/kg (group HE 
8.0). After administration of the HE, the animals remained under 
observation for a 14-day period to monitor signs of toxicity, 
according to criteria established by Malone (1997). The animals 
were weighed weekly by group (sex/dose), with the mean value for 
each group being recorded. At the end of this period, the surviving 
animals were sacrificed, and had the kidneys, heart, liver and 
spleen weighed and subjected to a macroscopic analysis. 
 
 
Assessment of sub-chronic toxicity 
 
The rats (R. norvegicus) were divided into three groups of six 
animals each (three male and three female). The groups were 
treated (v.o) with A. carambola L. HE at doses of 0.125 g/kg (HE 
0.125) or 0.25 g/kg (HE 0.25), or water, for 60 days. During this 
interval, the body weight and consumption of food were determined 
three times a week, and the average weekly values of each group 
(sex/dose) were recorded. The behavioral parameters were also 
measured daily. At the end of the treatment period, the animals 
were subjected to a 12 h fast for subsequent blood collection and 
analysis of the following biochemical parameters: Glucose, urea, 
creatinine, total cholesterol, high density lipoprotein (HDL) 
cholesterol, triglycerides, albumin, total proteins, aspartame amino 
transferase, alanine amino transferase and alkaline phosphatase. 
Afterwards, the animals were sacrificed and selected organs 
(kidneys, lungs, heart, liver, spleen and pancreas) were analyzed 
macroscopically for the detection of possible alterations caused by 





The results of the experiments were expressed as mean ± standard 
error of the mean and submitted to analysis of variance (ANOVA), 
followed by Newman Keuls test, considering significant differences 
between the groups when p ≤ 0.05. The analyses were done with 






Preparation of hydroalcoholic extract (HE) 
 
The HE prepared from the A. carambola L. leaves pre-
sented a dark green color, with a residue that was easily 
soluble in water and a yield of 17.6%. 
 
 




Among the animals treated by oral route who received 
the lowest doses (0.5 and 1.0 g/kg), no significant changes 




were observed, similar to the animals in the control 
group. In relation to the animals treated with the doses of 
2.0 and 5.0 g/kg, in the first few hours following treat-
ment, some signs of toxicity were observed including 
convulsions and tachycardia (Table 1). From the second 
day, the animals were found to be sedated, although the 
intensity of this effect was not proportional to the dose 
employed. These effects occurred in both sexes, although 
the only animals that died were both female, one at each 
dose of HE over the course of the 14 days of observation 
(Table 1). No change in body weight was seen in the ani-
mals at any of the doses employed (Table 2). As a result 
of this profile of mortality, the mean lethal dose (LD50) 
could not be determined in these animals. Among the 
mice treated with the HE by intraperitoneal route that 
received the lowest doses (0.5 and 1.0 g/kg), no signi-
ficant changes were noted; however, in the animals 
treated with the doses of 2.0 and 5.0 g/kg, some signs of 
toxicity such as abdominal pain, grouping, con-vulsions 
and tachycardia were observed in the first few hours after 
treatment, and these can be seen in Table 1. From the 
second day onwards, the animals exhibited sedation and 
death proportional to the dose employed. These effects 
occurred in both sexes, although mortality only occurred 
in females at a dose of 2.0 g/kg, and in males and 
females at a dose of 5.0 g/kg, as shown in Table 1. Once 
again, as a result of the profile of mortality in these animals, 
the mean lethal dose (LD50) could not be determined. 
Significant weight loss was not seen in the animals 
(Table 2). Macroscopic examination of the kidneys, heart, 
liver and spleen of the surviving animals did not reveal 
any relevant changes. Furthermore, there were no chan-





The rats that received higher doses of HE by the intra-
peritoneal route (2.0 and 3.0 g/kg) presented a mortality 
index proportional to the dose, as can be seen from 
Table 4. The LD50 of the HE of A. carambola L. in rats 
treated by this route was 1.49 g/kg. Among the treated 
animals that were given the lowest doses (0.5 and 1.0 
g/kg), no significant behavioral changes were observed, 
which was a similar result to that seen in the control 
group. In relation to the rats treated with the doses of 2.0 
and 3.0 g/kg, in the first few hours after treatment, some 
signs of toxicity were observed which are presented in 
Table 4; these were piloerection, writhing, sedation and 
depression. With this treatment the animals died within a 
few hours of the administration of the extract. Among the 
rats treated by oral route no behavioral changes were 
noted and none of the animals died (Table 4). The acute 
toxicity in rats was not associated with any detectable 
macroscopic changes in the organs analyzed (kidneys, 
liver, spleen, heart and pancreas) after the 14 days of 
observation. Small superficial inclusions of extract were 
found in the liver of the only surviving animal treated by




Table 1. Effect of single oral and intraperitoneal dose of Averrhoa carambola L. extract in mice. 
 
Route – dose (g/kg) Gender D/T Latency (h) Symptom 
Oral route     
Control 
M 0/5 - None 
FM 0/5 - None 
0.5 
M 0/5 - None 
FM 0/5 - None 
1.0 
M 0/5 - None 
FM 0/5 - None 
2.0 

















LD50= -     
Intraperitoneal route     
Control 
M 0/5 - None 
F 0/5 - None 
0.5 
M 0/5 - None 
F 0/5 - None 
1.0 
M 0/5 - None 
F 0/5 - None 
2.0 

















LD50= -     
 
All treated mice (n=10 in each group; 5 males and 5 females) were carefully examined for up to 14 days after 
the treatment for adverse effects including behavioral changes, lethality and latency of death. D/T, number of 
dead mice / number of treated mice; none, no symptoms observed during the observation period; latency, time 




intraperitoneal route with the dose of 2.0 g/kg. No chan-
ges in organ weights were observed. 
 
 
Assessment of sub-chronic toxicity 
 
The animals treated with the HE of A. carambola L. for 60 
days at the doses of 0.125 and 0.25g/kg did not present 
any behavioral changes during the period of treatment. In 
addition, no deaths were recorded during the treatment. 
In relation to the body weight of the animals, treatment 
with the HE of A. carambola L. did not cause any change 
in this parameter (Table 5). The profile of food consump-
tion was also found to be unaltered in the treated 
animals, when compared to the control group. Treatment 
with the extract of A. carambola L. did not lead to any 
macroscopic changes in the vital organs (kidneys, lung, 
heart, liver, spleen and pancreas) or to changes in the




Table 2. Effect on body weight in mice after single oral administration of Averrhoa carambola L. extract. 
 
Group Sex D0 (g) D7 (g) D14 (g) 
Control 
M 26.26± 1.09 28.00± 1.32 27.74± 1.14 
F 19.86± 0.78 19.98± 0.70 20.46± 0.75 
A. carambola (0.5 g/kg) 
M 24.68± 1.41 26.10± 1.66 26.60± 1.69 
F 21.16± 0.89 21.42± 0.90 22.12± 0.92 
A. carambola (1.0 g/kg) 
M 26.80± 2.91 27.42± 2.16 27.74± 2.24 
F 22.44± 1.90 22.88± 1.80 23.24± 1.76 
A. carambola (2.0 g/kg) 
M 27.80± 2.46 28.07± 2.32 28.35± 2.15 
F 20.70± 0.71 21.15± 0.47 21.73± 0.49 
A. carambola (5.0 g/kg) 
M 26.75± 1.65 28.00± 1.95 27.70± 2.25 
F 21.05± 1.30 21.80± 1.37 22.60± 1.38 
 
All treated mice (n=10 in each group; 5 males and 5 females) were carefully examined for up to 14 days after the 




Table 3. Weight of organs from surviving mice 14 days after administration of a single dose of the extract of Averrhoa 
carambola L.  
 
Group Kidney (g) Heart (g) Liver (g) Spleen (g) 
Control 0.41± 0.02 0.13± 0.004 1.64± 0.09 0.10± 0.006 
A. carambola (0.5 g/kg) 0.41± 0.02 0.14± 0.004 1.64± 0.10 0.10± 0.006 
A. carambola (1.0 g/kg) 0.41± 0.02 0.13± 0.005 1.68± 0.12 0.10± 0.006 
A. carambola (2.0 g/kg) 0.40± 0.09 0.12± 0.005 1.29± 0.10 0.11± 0.01 
A. carambola (5.0 g/kg) 0.40± 0.08 0.14± 0.01 1.37± 0.04 0.11± 0.007 
 
The values represent the means of the organ weights (in grams) ± S.E.M. All treated mice (n=3-10 in each group; males and 
females) were carefully examined for up to 14 days after the treatment. No significant difference was between control and 




Table 4. Effect of single oral and intraperitoneal dose of Averrhoa carambola L. extract in rats. 
 
Route – dose (g/kg) Sex D/T Latency (h) Symptom 
Oral route     
Control 
M 0/5 - None 
FM 0/5 - None 
1.0 
M 0/5 - None 
FM 0/5 - None 
2.0 
M 0/5 - None 
FM 0/5 - None 
5.0 
M 0/5 - None 
FM 0/5 - None 
8.0 
M 0/5 - None 
FM 0/5 - None 
LD50= -     
Intraperitoneal route     
Control 
M 0/5 - None 
FM 0/5 - None 
0.5 
M 0/5 - None 
FM 0/5 - None 
1.0 M 0/5 - None 
 FM 0/5 - None 




Table 4. Contd. 
 
2.0 
M 4/5 2-4 
Piloerection, Sedation, 
Writhing, Convulsions 




M 5/5 2-4 
Piloerection, Sedation, 
Writhing, Convulsions 
FM 5/5 2-4 
Piloerection, Sedation, 
Writhing, Convulsions 
LD50= 1.49 g/kg     
 
All treated rats (n=10 in each group; 5 males and 5 females) were carefully examined for up to 14 days after the 
treatment for adverse effects including behavioral changes, lethality and latency of death. D/T, Number of dead 
rats / number of treated rats; none, no symptoms observed during the observation period; Latency, time to 




Table 5. Effect on body weight in rats after daily oral administration of Averrhoa carambola L. extract.  
 
Group Sex D0 D15 D30 D45 D60 
Control 
M 234.6± 14.44 235.4± 15.34 238.9± 13.77 257.0± 18.96 278.6± 14.26 
FM 212.4± 12.07 213.5± 12.07 217.4± 11.54 241.2± 11.70 257.5± 11.88 
       
Averrhoa carambola (0.125 g/kg) 
M 245.5± 4.58 248.6± 5.11 252.1± 0.73 242.3± 6.63 276.8± 9.67 
FM 215.6± 4.62 218.7± 4.92 225.4± 3.94 212.4± 6.63 246.9± 9.65 
       
Averrhoa carambola (0.25 g/kg) 
M 229.4±7.93 231.5±8.17 235.1±7.98 262.2±6.69 271.6±8.36 
FM 202.3± 5.24 204.9± 5.62 199.5± 3.59 232.5± 6.81 241.9± 8.43 
 
All treated mice (n=6 in each group; 3 males and 3 females) received the extract orally at daily doses of 0, 0.125 and 0.25 g/kg for up 60 days. 




Table 6. Effects of daily oral administration of Averrhoa carambola L. extract for up 60 days on the biochemical 
parameters of rats. 
 
Parameter  Control 0.125 g/kg 0.25 g/kg 
COL – T (mg/dL) 57.4±5.62 57.5±5.50 75.7±7.51 
GLI (mg/dL) 152.2±14.43 109.5±11.50 186.3±24.6 
ALB (g/dL) 2.89±0.18 2.74±0.46 2.78±0.12 
TRI (mg/dL) 73.50±15.61 49.33±21.79 88.00±23.64 
AST (U/l) 100.3±6.65 130.5±31.50 107.7±20.10 
ALT (U/l) 36.25±4.75 39.00±8.00 22.00±7.00 
URE (mg/dL) 878.8±50.01 848.5±8.50 778.7±41.33 
CRE (mg/dL) 1.03±0.11 1.25±0.05 1.00±0.057 
PT (d/dL) 9.08±1.12 7.75±0.95 7.20±0.40 
ALP (U/l) 44.25±10.09 29.00±1.00 48.67±7.42 
COL – HDL (mg/dL) 9.75±1.65 4.33±2.60 6.00±2.65 
 
Data are expressed as mean ± S.E.M (n=6). COL-T, Total cholesterol; GLI, glucose; ALB, albumin; TRI, triglyceride; AST, 
aspartate aminotransferase; ALT, alanine amino transferase; URE, urea; CRE, creatinine; PT, total protein; ALP, alkaline 
phosphatase; COL- HDL, high density lipoprotein.  *p≤0.05 compared with the control group. No significant difference was 




weights of the organs. At the end of the treatment, analy-
sis of the blood of these animals showed no statistically 
significant changes in the selected biochemical para-
meters (Table 6). 
DISCUSSION 
 
In many low and middle income countries, folklore or 





system to which people are referred for their primary 
health care. The use of herbal remedies is further sub-
stantiated by its affordability, knowledge of medicinal 
plants and the belief that they are harmless. The increase 
in the number of users as opposed to the scarcity of 
scientific evidence on the safety of medicinal plants has 
raised concerns regarding toxicity and detrimental effects 
of these remedies. Medicinal plants commonly contain 
various bioactive principles which have the potential to 
cause beneficial and/or harmful effects. To optimize their 
safe use as plant-based medicines, we should, despite 
the historical experience of application in humans and 
animals, evaluate the toxicity of these medicinal herbs (Li 
et al., 2010). The assessment of the extract of A. carambola 
L. in this study was prompted by the fact that this form of 
plant medicine closely mimics the traditional dosage 
form, while it also represents a convenient form that can 
be standardized in terms of its chemical or physical con-
stituents, and also is easily stored. Thus, the assessment 
of the safety of this dosage form of A. carambola L. is 
greatly facilitated. The present study was designed to 
investigate the pre-clinical toxicological effects of the 
hydroalcoholic extract of the leaves of A. carambola L. 
administered by oral (acute and subchronic effects) and 
intraperitoneal (acute effect) routes in order to determine 
the safety of the extract.  
The goal of tests of acute toxicity is to define the lethal 
dose of a drug administered in a single dose or in several 
doses intercalated over a short period of time, as part of 
the initial pharmacological triage during which the action 
of the drugs on important functions is observed (Déciga-
Campos et al., 2007). In addition, toxicity assessments 
are carried out with the objective of determining the 
potential of new substances and products to cause harm 
to human health. Tests of acute systemic toxicity are 
used to classify and appropriately label substances 
according to their lethal or toxic potential as established 
by relevant legislation (Valadares, 2006). 
Among the animals in the control groups (rats and 
mice), no significant physiological changes were observed 
in either of the sexes. The mice that received the HE at 
lower doses (0.5 or 1.0 g/kg) also did not present signi-
ficant changes. By contrast, the mice treated with HE at 
doses of 2.0 or 5.0 g/kg presented signs of toxicity, such 
as convulsions and tachycardia, in the first four hours 
after the treatment. From the second day on, the animals 
appeared sedated. These effects occurred in both sexes; 
however, the only animals that died were two females 
(Table 1). In the mice that received the HE via intraperi-
toneal route, behavioral changes were observed with 
doses of 2.0 or 5.0 g/kg HE in the first four hours after 
treatment, including writhing, grouping and convulsions. 
On the second day after treatment, the animals presented 
sedation and death proportional to the dose employed 
(Table 1). No significant change in body weight was 
observed in these animals (Table 2). Macroscopic exami-
nation of the kidneys, heart, liver and spleen of the survi- 




ving animals did not reveal any relevant changes; 
likewise, there was no significant change in the weight of 
these organs (Table 3). The study by Provasi et al. 
(2001) did not record any death among mice treated with 
a 3.5 g/kg dose; however, in that study, the period of 
monitoring of the animals was limited to four hours. This 
is important since although toxic effects can appear in 
multiple systems and organs, it is the liver that is most 
heavily affected both because of its anatomical position 
and because its cells concentrate the compounds to be 
metabolized, together with the resulting metabolites and 
the enzymes responsible for the metabolic process 
(Mendes, 1988).  
In the rats treated orally, there were no behavioral chan-
ges nor deaths with the doses employed (Table 4), nor 
were there macroscopic or weight changes in the organs 
analyzed after 14 days of observation. The rats that 
received HE via the intraperitoneal route at doses of 2.0 
and 3.0 g/kg presented an index of mortality proportional 
to the dose used (Table 4), and the mean lethal dose 
(LD50) of HE for the rats treated via intraperitoneal route 
was 1.49 g/kg. The signs of toxicity presented by these 
animals were piloerection, writhing, sedation and 
depression. Moreover, the animals died in the first two 
hours after receiving the extract. We know that the value 
of the mean lethal dose as a fundamental parameter for 
the definition of chemical toxicity is limited, since this test 
measures only the acute toxicity produced by a single 
dose, and not long-term toxicity, and also does not 
measure individual reactions (Rang et al., 2003). Besides 
this, doses in excess of the maximum dose for the 
evaluation of this parameter, which is 2 g/kg (Larini, 
1997), were used in this work.  
Studies of sub-chronic toxicity are also performed in the 
pre-clinical evaluation of drugs, in an attempt to identify 
any damage that the use of the drug under consideration 
could cause to biological systems in the medium- and 
long-term (Sorrentino et al., 2006). The animals treated 
with the HE of A. carambola L. leaves for 60 days at 
doses of 0.125 and 0.25 g/kg did not present any 
behavioral alterations or deaths in the treatment period. 
No significant changes in the weight of the animals were 
noted (Table 6); likewise, there were no significant 
changes in food consumption in the groups that received 
HE compared to the control group. There was no appa-
rent effect of the A. carambola L. HE on the selected 
organs, nor did they show any macroscopic alterations or 
changes in weight.  
In the analysis of blood samples, no statistically 
significant changes were observed in the biochemical 
parameters in the animals treated with HE, compared to 
the control group (Table 6). The assessment of the sub-
chronic toxicity of A. carambola L. involved examining 
liver function by assay of ALT, aspartate amino trans-
ferase (AST) and alkaline phosphatase (ALP), with no 
changes being found in relation to the control group at 
the  doses  employed.  These  data  are  similar  to  those  




reported by Provasi et al. (2001), who did not find 
significant changes in the levels of ALT and AST in rats. 
In the small animal clinic, abnormalities are commonly 
detected in the serum levels of these enzymes, which are 
considered sensitive indicators of hepatobiliary distur-
bances (Sharon and Center, 1995). 
A rise in serum enzyme activities may result from 
reversible or irreversible changes in cell permeability, the 
induction of microsomal enzymes or structural damage 
associated with necrosis, cholestasis or hepatocellular 
ischemia. Numerous pathological processes involving the 
liver can lead to proportionally distinct rises in liver en-
zymes, due to variation in the distribution of each specific 
enzyme in the hepatic lobule (Sharon and Center, 1995).  
The transaminases are enzymes that catalyze the inter-
conversion of amino acids and alpha-keto acids by trans-
fer of the amino group. They are widely distributed 
throughout the tissues, with AST predominantly found in 
the liver, heart, cardiac muscle, striated muscle, kidney 
and pancreas, while ALT is predominantly seen in the 
liver, kidney and heart. AST is present in the cytosol as 
well as in the mitochondria of hepatocytes. The plasma 
activity of this enzyme is controlled by an enzymatic 
release mechanism localized to the cell membrane of the 
hepatocyte. The rate of excretion of the transaminases is 
variable, with AST being eliminated more quickly than 
ALT (Miller and Gonçalves, 1999). The increased levels 
of amino transferases in the serum of animals treated 
with the extract may have resulted from the release of 
enzymes from the cells of the organ affected, or from a 
change in cell permeability (Rebecca et al., 2002). With 
regard to A. carambola L., to our knowledge, only one 
study in the literature has investigated the effect of acute 
toxicity of the hydroalcoholic extract of the leaves in rats 
and mice, with the authors showing that the hepatic 
enzymes ALT) and AST were unchanged in relation to 
the control group (Provasi et al., 2001). 
ALP is a phosphohydrolase enzyme found in various 
tissues, with higher concentrations in the liver, the epithe-
lium of the biliary tract and in the bones. In the liver, ALP 
is secreted by the hepatocytes and by the cells of the 
mucosa of the biliary tract. In general, any active hepato-
pathy can increase the values of ALP, but the greatest 
increases in the levels of the enzyme occur in cases of 
obstruction of the biliary tract. In the case of hepatotoxic 
drugs, there is a smaller rise in enzyme levels (Miller and 
Gonçalves, 1999). 
Urea is produced in the liver and excreted by the kid-
neys. When kidney filtration is insufficient, urea accumu-
lates in the blood. Some drugs are capable of enzyme 
induction, and can consequently increase toxicity. Accor-
ding to literature, biochemical assays that show increased 
urea and creatinine in animals subjected to treatment 
with plant-based drugs may indicate that the effect of the 
drug interfere with the metabolism and function of the 
kidney (Baliga et al., 2004). Raised levels of total choles-





the risk of cardiovascular disease. Subchronic treatment 
with the HE of A. carambola L. did not alter these para-
meters. This result may be explained by the fact that rats 
are resistant to the development of hypercholesterolemia 
and atherosclerosis, possibly as a result of the increased 
conversion of cholesterol to biliary acids in the liver 
(Soares et al., 2005). 
It should be emphasized that the interpretation of labo-
ratory exams is much more complex than a simple com-
parison with reference values, classifying the test results 
as normal or abnormal according to the limits for the 
reference, and then comparing the results with standards 
that indicate the presence of certain diseases (Ravel, 
1997). With regard to reference data in laboratory ani-
mals, the analysis and interpretation of the results are 
even more difficult, since the scientific literature lacks re-
ference values for laboratory analyses in the animal species 
used in the present work. Consequently, the results 
obtained following the treatment of animals with the HE of 
A. carambola L. were compared by statistical methods 
with the data obtained in the control groups, according to 
methodology employed by Daher et al. (2006) and 
Thanabhorn et al. (2006), who assessed the toxicity of 
plants in animals and used their own control groups as 





The present acute and sub-chronic pre-clinical toxicolo-
gical study in Wistar rats and Swiss mice using the 
hydroalcoholic extract of A. carambola L. leaves demon-
strated that the plant species investigated has relatively 
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